We are contrasting Intec Pharma Ltd. (NASDAQ:NTEC) and Pfenex Inc. (NYSEAMERICAN:PFNX) on their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. They both are Biotechnology companies, competing one another.
Earnings and Valuation
Table 1 shows gross revenue, earnings per share and valuation of the two companies.
Table 2 provides us the net margins, return on equity and return on assets of both companies.
Institutional and Insider Ownership
Roughly 39.64% of Intec Pharma Ltd. shares are owned by institutional investors while 81.6% of Pfenex Inc. are owned by institutional investors. Intec Pharma Ltd.’s share owned by insiders are 11.81%. On the other hand, insiders owned about 0.1% of Pfenex Inc.’s shares.
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
For the past year Intec Pharma Ltd. has weaker performance than